Author(s)
Purpose
- Pathology:
Male genital diseases
Neoplasms
- Disease:
Genital neoplasms, Male
[ only metastatic prostate neoplasms ]
- Objective:
To be a pragmatic outcome measure for clinical trials in symptomatic men with advanced hormone-resistant prostate cancer
- Population for intended use:
Adult
Male
Characteristics
- Type of instrument:
Health-Related Quality of Life - HRQL (incl. health status)
- Administration mode:
Self-administered
- Number of items:
10
- Recall/Observation period:
During the past 24 hours
Language(s)
- Original language:
English
- List of existing translations:
The translations listed below may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study.
This list of translations is subject to constant changes, therefore please check the status of translations with MAPI Research Trust / the developers / copyright holders / distributors.
Bibliographic reference(s) of the original questionnaire
Last update: April 2012
Last update in collaboration with the author: May 2008
